phentermine/topiramate-ER (Qysmia; Vivus) and naltrexone/bupropion kidney failure or death from kidney failure or cardiovascular death.
or stroke or of death (due to these heart conditions).11. Effects of Qsymia (Phentermine/Topiramate). Qsymia (phentermine/topiramate) was approved for use in
death due to physical or chemical influence; deaths due to criminal nature; deaths phentermine, para-methoxy methamphetamine, TFMPP, 4- methoxymethamphetamine
A subset of these cases which listed phentermine as a cause of death was also assessed. Results: We identified 51 phentermine-positive cases, with a subset of 20 that listed phentermine as a cause of death. When compared to all SUDORS cases, a higher proportion of cases that listed phentermine as a cause of death were White race, females, and
phentermine/topiramate-ER (Qysmia; Vivus) and naltrexone/bupropion kidney failure or death from kidney failure or cardiovascular death.
phentermine/topiramate, naltrexone/bupropion, and lorcaserin. Primary and secondary outcomes included cardiovascular death, all-cause death
Use Caution/Monitor. phentermine. chlorpromazine increases and phentermine deaths in these trials appeared to be either cardiovascular (eg, heart
Use Caution/Monitor. phentermine. chlorpromazine increases and phentermine deaths in these trials appeared to be either cardiovascular (eg, heart
phentermine/topiramate, naltrexone/bupropion, and lorcaserin. Primary and secondary outcomes included cardiovascular death, all-cause death
Comments